Cargando…

May Measurement Month 2017–2019: an analysis of blood pressure screening results from Dominican Republic( )

Arterial hypertension is the main risk factor that contributes to cardiovascular disease and represents a leading cause of morbidity and mortality globally. May Measurement Month (MMM) is a global screening campaign with the aim of improving awareness of hypertension at the individual and population...

Descripción completa

Detalles Bibliográficos
Autores principales: Valdez-Tiburcio, Osiris, Gonzalez-Medina, Angel, Valdez-Valoy, Laura, Santillan-Pascual, Marcos, Baez-Noyer, Nelson, Diaz-Montero, Belianix, Wang, Wei, Beaney, Thomas, Poulter, Neil R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547510/
https://www.ncbi.nlm.nih.gov/pubmed/36225279
http://dx.doi.org/10.1093/eurheartjsupp/suac040
Descripción
Sumario:Arterial hypertension is the main risk factor that contributes to cardiovascular disease and represents a leading cause of morbidity and mortality globally. May Measurement Month (MMM) is a global screening campaign with the aim of improving awareness of hypertension at the individual and population level, an initiative that has been supported in the Dominican Republic (DR) since 2017. Adults (≥18 years) were recruited by sampling in different places in the DR, three blood pressure (BP) readings were performed per participant, and data on risk factors and comorbidities were collected. Hypertension was defined as systolic BP ≥140 mm Hg, diastolic BP ≥ 90 mm Hg (mean of second and third readings), and/or taking antihypertensive medication. Multiple imputation was used to estimate participants’ mean BP when three readings were not available. Of 3693 participants, 2134 (57.8%) had hypertension, of whom 1646 (77.1%) were taking medication, but only 38.6% of those on treatment had their BP under control(<140/90 mmHg). The remaining 61.4% of the participants received inadequate treatment. A total of 66% of treated patients were taking a single antihypertensive drug. MMM provides an important platform for the standardized compilation of BP data and the creation of awareness of hypertension in the DR and other nations of the world. The data generated from the 2017–2019 MMM campaigns highlight the importance of adequate detection, knowledge, and control of BP.